![]() |
|
|
Vol. 285, Issue 2, 800-804, May 1998
Department of Anesthesiology, University of
Erlangen-Nürnberg, Erlangen, Germany
During Gram-negative bacterial infections, lipopolysaccharide (LPS)
interacts with monocyte/macrophage receptors, resulting in a host
defense response. Activation of intracellular signal transduction
pathways implicating various protein kinase and phospholipases is
crucial in activating the transcription of genes encoding
proinflammatory cytokines and inducible nitric oxide synthase (iNOS).
In this article, we demonstrate that in mouse, endotoxin shock
activation of phosphatidylcholine-specific phospholipase C (PC-PLC)
plays a major role in controlling the inflammatory response. Inhibition of PC-PLC by the specific inhibitor tricyclodecan-9-yl-xanthogenate (D609) before LPS reduced the release of interleukin-1
,
interleukin-6 and nitric oxide (NO) in vivo. In
contrast, tumor necrosis factor-
serum levels were not altered by
the pretreatment with D609. Consequently, survival from endotoxin shock
of D609-treated animals was significantly improved compared with
control animals (45% vs. 20%). Thus, inhibition of
PC-PLC can reduce the inflammatory response to LPS and may serve as a
novel approach to therapy of sepsis.
This article has been cited by other articles:
![]() |
A. Faisal, A. Saurin, B. Gregory, B. Foxwell, and P. J. Parker The Scaffold MyD88 Acts to Couple Protein Kinase C{epsilon} to Toll-like Receptors J. Biol. Chem., July 4, 2008; 283(27): 18591 - 18600. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. McGettrick, E. K. Brint, E. M. Palsson-McDermott, D. C. Rowe, D. T. Golenbock, N. J. Gay, K. A. Fitzgerald, and L. A. J. O'Neill Trif-related adapter molecule is phosphorylated by PKC{varepsilon} during Toll-like receptor 4 signaling PNAS, June 13, 2006; 103(24): 9196 - 9201. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Giron-Calle, K. Srivatsa, and H. J. Forman Priming of Alveolar Macrophage Respiratory Burst by H2O2 Is Prevented by Phosphatidylcholine-Specific Phospholipase C Inhibitor Tricyclodecan-9-yl-xanthate (D609) J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 87 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zhou, C. M. Lauderback, T. Yu, S. A. Brown, D. A. Butterfield, and J. S. Thompson D609 Inhibits Ionizing Radiation-Induced Oxidative Damage by Acting as a Potent Antioxidant J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 103 - 109. [Abstract] [Full Text] |
||||
![]() |
T. Krakauer Suppression of Endotoxin- and Staphylococcal Exotoxin-Induced Cytokines and Chemokines by a Phospholipase C Inhibitor in Human Peripheral Blood Mononuclear Cells Clin. Vaccine Immunol., March 1, 2001; 8(2): 449 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Valledor, M. Comalada, J. Xaus, and A. Celada The Differential Time-course of Extracellular-regulated Kinase Activity Correlates with the Macrophage Response toward Proliferation or Activation J. Biol. Chem., March 15, 2000; 275(10): 7403 - 7409. [Abstract] [Full Text] [PDF] |
||||